<DOC>
	<DOC>NCT03032848</DOC>
	<brief_summary>To evaluate the difference of three vaginal estrogens creams comparative with placebo on improvement of hormonal cytology, local and systemic climacteric complaints, as well as its endometrial security.</brief_summary>
	<brief_title>Vaginal Estrogens Comparative Trial on Pelvic Organ Prolapse Patients</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prolapse</mesh_term>
	<mesh_term>Pelvic Organ Prolapse</mesh_term>
	<mesh_term>Vaginitis</mesh_term>
	<mesh_term>Endometrial Hyperplasia</mesh_term>
	<mesh_term>Atrophic Vaginitis</mesh_term>
	<mesh_term>Estrogens, Conjugated (USP)</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<criteria>post menopause women normal oncotic cytology and mammogram any grade of pelvic organ prolapse with surgery indication and ultrasound with endometrium measure less than 5 mm vaginal bleeding hormonal replacement on the past three months renal or hepatic desease porfiria past venous thromboembolism; ulcerated prolapse</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>